Colin Seaman is the boy with the Harry Potter cells
- OPACC
- Jan 18, 2023
- 1 min read
"While developing a treatment plan, Lee introduced the family to a revolutionary treatment option for some patients with leukemia. Colin was a candidate for this new treatment, one that uses the body’s own T-cells, part of the body’s immune system, to fight the disease. The first therapy developed using this revolutionary technology was approved in 2017. Since then, five other therapies have been approved, all for cancers of the blood."
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments